大型抑郁症患者大脑不同区域的特异表达和共同的潜在治疗药物:生物信息学分析
1The First Affiliated Hospital of Dalian Medical University, A222 Zhongshan Road, Dalian, Liaoning Province, China.
Journal of affective disorders
|April 26, 2025
概括
这项研究确定了主要的基因和分子通路在主要抑郁症 (MDD) 患者的不同大脑区域. 生物信息学分析揭示了MDD的潜在诊断标记和治疗点,改善了对这种复杂的大脑疾病的理解.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物信息学是一种生物信息学.
背景情况:
- 大型抑郁症 (MDD) 是一种广泛和残疾的心理健康状况,分子基础不明.
- 了解特定大脑区域的基因表达差异对于确定MDD的新型诊断和治疗策略至关重要.
研究的目的:
- 在MDD患者中调查杏仁体,前环皮质和背侧前额皮质的基因表达变异.
- 通过全面的生物信息学分析,确定MDD的潜在诊断生物标志物和治疗点.
- 根据基因表达数据开发MDD的预测模型.
主要方法:
- 分析了来自五个GEO数据集的全转录组测序数据.
- 差异表达基因 (DEGs) 使用R包"limma"进行了鉴定.
- 构建了蛋白质-蛋白质相互作用网络,确定了核心基因,并使用机器学习模型 (LASSO回归,ROC分析) 进行预测和验证.
主要成果:
- 在杏仁体中发现了342个DEG,在前环皮质中发现了76个DEG,在背侧前额皮质中发现了64个DEG.
- 关键的诊断基因如COX5A,SST,CTSG,IL18RAP,LMO2,MS4A7和VGF被精确地确定.
- 机器学习模型实现了高的预测准确性 (AUC从0.776到0.928不等),并且涉及了氧化酸化和MAPK信号传递等重要的途径.
结论:
- 这项研究提供了对受MDD影响的不同脑区基因表达的详细生物信息学分析.
- 确定了核心基因和途径,为MDD的发病过程提供了重要的见解,并为未来的治疗干预提供了潜在的目标.
- 这些发现支持对重度抑郁症的数据驱动诊断和治疗策略的开发.
相关概念视频
Brain Imaging
195
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
195
Antidepressant Drugs: MAOIs and Other Agents
164
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
164
Antidepressant Drugs: Overview
325
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
325
Depression: Overview
197
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
197


